Summit Therapeutics Inc (SMMT)

04:26 AM

Summit: A Cautious Bet Backed By Anti-VEGF & Insider Buying (NASDAQ:SMMT) - Seeking Alpha

04:26 AM

12:46 PM

Has Summit Therapeutics Inc. found a price floorJuly 2025 Trends & Free Weekly Chart Analysis and Trade Guides - newser.com

12:46 PM

Nov 18, 2025

Wolfe Research Initiates Coverage of Summit Therapeutics (SMMT) with Peer Perform Recommendation - Nasdaq

Nov 18, 2025

Nov 18, 2025

Summit Therapeutics at Jefferies London: Strategic Progress in Cancer Trials By Investing.com - Investing.com Canada

Nov 18, 2025

Nov 18, 2025

Wolfe Research Initiates Coverage on SMMT with 'Peer Perform' Ra - GuruFocus

Nov 18, 2025

Nov 18, 2025

Transcript : Summit Therapeutics Inc. Presents at Jefferies London Healthcare Conference 2025, Nov-18-2025 03 - MarketScreener

Nov 18, 2025

Nov 16, 2025

What institutional flow reveals about Summit Therapeutics Inc.GDP Growth & Real-Time Buy Zone Alerts - newser.com

Nov 16, 2025

Nov 16, 2025

What MACD and RSI say about Summit Therapeutics Inc.July 2025 Closing Moves & Advanced Swing Trade Entry Alerts - newser.com

Nov 16, 2025

Nov 16, 2025

Is Summit Therapeutics Inc. building a consolidation baseWeekly Investment Recap & Verified Stock Trade Ideas - newser.com

Nov 16, 2025

Nov 16, 2025

News impact scoring models applied to Summit Therapeutics Inc.Options Play & Technical Pattern Alert System - newser.com

Nov 16, 2025

Nov 15, 2025

Is Summit Therapeutics Inc. showing signs of accumulationJuly 2025 Pullbacks & High Yield Stock Recommendations - newser.com

Nov 15, 2025

Nov 14, 2025

Should you hold or exit Summit Therapeutics Inc. nowJuly 2025 Highlights & Free Verified High Yield Trade Plans - newser.com

Nov 14, 2025

Nov 14, 2025

Is Summit Therapeutics Inc. stock a safe haven assetForecast Cut & Short-Term High Return Ideas - Fundação Cultural do Pará

Nov 14, 2025

Nov 11, 2025

Analyzing Summit Therapeutics Inc. with risk reward ratio chartsWeekly Trend Summary & Community Trade Idea Sharing Platform - newser.com

Nov 11, 2025

Nov 11, 2025

Can Summit Therapeutics Inc. hit a new high this monthInsider Selling & Weekly Return Optimization Plans - newser.com

Nov 11, 2025

Nov 10, 2025

Summit Therapeutics (SMMT) Reports Positive Results from the Phase III HARMONi Trial - Yahoo Finance

Nov 10, 2025

Nov 10, 2025

Responsive Playbooks and the SMMT Inflection - news.stocktradersdaily.com

Nov 10, 2025

Nov 10, 2025

Summit and Akeso ivonescimab’s shows significant OS benefit - The Pharma Letter

Nov 10, 2025

Nov 08, 2025

Clear Street Remains a Buy on Summit Therapeutics (SMMT) - The Globe and Mail

Nov 08, 2025

Nov 07, 2025

Insiders Are Buying These 3 Stocks Hand Over Fist - AOL.com

Nov 07, 2025

Nov 07, 2025

Summit Therapeutics Reports Positive Phase III Trial Results - MSN

Nov 07, 2025

Nov 07, 2025

Ivonescimab Plus Chemotherapy Demonstrates a Statistically Significant Benefit in Overall Survival with a Hazard Ratio of 0.74 in 2L+ Treatment of Patients with EGFRm NSCLC in HARMONi-A Study Conducted by Akeso in China - Placera.se

Nov 07, 2025

Nov 07, 2025

Summit Therapeutics Says Ivonescimab, Chemotherapy Combination Shows Benefit in Treating Lung Cancer - MarketScreener

Nov 07, 2025

Nov 07, 2025

Summit Therapeutics Inc Reports Positive Phase III Trial Results - TradingView

Nov 07, 2025

Nov 07, 2025

[8-K] Summit Therapeutics Inc. Reports Material Event | SMMT SEC FilingForm 8-K - Stock Titan

Nov 07, 2025

Nov 07, 2025

Summit (NASDAQ: SMMT): ivonescimab combo OS 16.8 vs 14.1 mo in EGFRm NSCLC - Stock Titan

Nov 07, 2025

Nov 05, 2025

Will Summit Therapeutics Inc. stock outperform growth indexesSwing Trade & Verified Short-Term Trading Plans - fcp.pa.gov.br

Nov 05, 2025

Nov 05, 2025

Applying sector rotation models to Summit Therapeutics Inc.Weekly Profit Analysis & AI Powered Market Entry Strategies - newser.com

Nov 05, 2025

Nov 05, 2025

Transforming Lung Cancer Care Through Targeted Science and Patient-First InnovationSummit Therapeutics - Oncodaily

Nov 05, 2025